IIT Delhi Launches MS in Healthcare Technology for Medical Professionals, Starting January 2025
The Indian Institute of Technology (IIT) Delhi has announced the launch of a new Master of Science (Research) in Healthcare […]
The Indian Institute of Technology (IIT) Delhi has announced the launch of a new Master of Science (Research) in Healthcare […]
The National Institute of Pharmaceutical Education and Research, Ahmedabad (NIPER-A), claims to have developed a new class of compounds for […]
Former Microsoft India Chairman Ravi Venkatesan, who helped build and expand Microsoft’s largest presence outside of the USA in India, […]
Health Level Seven International (HL7), one of the leaders in developing interoperability standards for healthcare IT has announced its decision […]
Ensure that laboratories are providing accurate testing results in vitamin D testing methodology. Dr JS Suri, Director-Dr Suri Lab When […]
Key to Increase Compliance in Patients with Chronic Disease and Reduce Cost of Treatment The term Tele-Triage represents one of […]
Citing significant variations in pediatric radiopharmaceutical doses and package inserts lacking pediatric doses, the authors of an article appearing in […]
Health Level Seven® International (HL7®) International have announced an agreement to create a complementary process to foster interoperability that will […]
As the CFO of Columbia Asia Hospitals, Jagannath MS, delivers healthcare through the best model of hospitals and medical excellence.
[This article was published in the May 2011 issue of the eHEALTH Magazine (https://www.ehealthonline.org) ] The patient monitoring market is an expanding and profitable sector in the global healthcare industry.
[This article was published in the April 2011 issue of the eHEALTH Magazine (https://www.ehealthonline.org) ] The integration of ICT into the health sector has globally empowered the status of health in recent years
Researchers at Imperial College London have discovered a protein that triggers rheumatoid arthritis.
Biotechnology company Biogen Idec has announced the introduction of TYSABRI (natalizumab) the first humanized, monoclonal antibody for the treatment of relapsing remitting MS in India.